海角直播 Applauds Reintroduction of PASTEUR Act to Combat AMR
Key Points
- 海角直播 thanks Senators Michael Bennet, Todd Young, Kirsten Gillibrand, Mike Rounds and John Hickenlooper for reintroducing the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act.
- More than 35,000 Americans die each year because of AMR, and treating just 6 of the leading AMR threats in the U.S. accounts for $4.6 billion in annual health costs.
- The PASTEUR Act would establish a new avenue of federal support for the development of new and critical antibiotics and antifungals, and 海角直播 backs new improvements made to the bill.
| The Honorable Michael Bennet 261 Russell Senate Office Building Washington, D.C. 20510 |
The Honorable Todd Young 185 Dirksen Senate Office Building Washington, D.C. 20510 |
| The Honorable Kirsten Gillibrand 478 Russell Senate Office Building Washington, D.C. 20510 |
The Honorable Mike Rounds 716 Hart Senate Office Building Washington, D.C. 20510 |
| The Honorable John Hickenlooper 316 Hart Senate Office Building Washington, D.C. 20510 |
Dear Senators Bennet, Young, Gillibrand, Rounds and Hickenlooper,
On behalf of 海角直播, a global scientific society of more than 38,000 members whose mission is to shape the future of the microbial sciences to tackle some of the world’s most pressing challenges, thank you for reintroducing the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act. 海角直播 is pleased to offer our support for the PASTEUR Act to address the rising problem of antimicrobial resistance (AMR).
AMR is a serious public health threat that undermines U.S. public health preparedness, with the Centers for Disease Control and Prevention (CDC) reporting more than die annually as a result of AMR, and treating 6 of the leading AMR threats in the U.S. accounts for in annual health costs. Passage of the PASTEUR Act is critical to stimulate antimicrobial discovery and development at a time when the current pipeline of novel products in development is insufficient to meet the continued threat of antimicrobial resistant pathogens.
The PASTEUR Act would establish a new avenue of federal support for the development of new antibiotics and antifungals that are critically needed for patient care. 海角直播 is also supportive of key improvements made to the bill, including a more objective and rigorous process for determining which drugs qualify for federal contracts to ensure the bill delivers the most clinically meaningful new treatments, as well as expanded antimicrobial stewardship provisions, which are essential to ensuring the antimicrobials we have are effective for as long as possible.
海角直播鈥痑nd its members stand ready to work with Congress to combat AMR. If we can be of further鈥痑ssistance, please contact JR Kane, Government Relations Manager at 海角直播, at鈥jkane@asmusa.org.
厂颈苍肠别谤别濒测,&苍产蝉辫;鈥赌&苍产蝉辫;
Amalia Corby
Director of Federal Affairs
海角直播